Table 1.

Demographic and clinicopathological features of patients

Case No.	Age (years)	Gender	Location	pTNM	TB	PDCs	NED (months)	Follow‐up (months)
1	75	M	Transverse colon	T2N0M0	Bd1	G3	34	34
2	74	F	Caecum	T2N0M0	Bd1	G1	27	27
3	79	F	Descending colon	T2N1bM0	Bd3	G1	31	31
4	81	F	Descending colon	T3N0M0	Bd1	G1	32	32
5	70	M	Ascending colon	T3N0M0	Bd2	G1	30	30
6	71	M	Ascending colon	T3N0M0	Bd2	G1	3	4; DUC
7	71	M	Transverse colon	T3N0M0	Bd1	G2	38	38
8	81	F	Caecum	T3N0M0	Bd1	G1	37	37
9	69	M	Caecum	T3bN0M0	Bd3	G1	36	36
10	70	M	Transverse colon	T3N1M0	Bd2	G1	33	33
11	81	M	Transverse colon	T3N1bM0	Bd2	G2	0	0; DPC
12	73	F	Transverse colon	T3N1bM0	Bd2	G2	27	27
13	63	M	Descending colon	T3N1bM0	Bd2	G3	34	34
14	57	M	Transverse colon	T3N1bM0	Bd2	G3	30	35; LR + DM
15	58	M	Ascending colon	T3N1bM0	Bd2	G3	37	37
16	54	F	Transverse colon	T3cN1bM0	Bd1	G1	35	35
17	75	M	Transverse colon	T3N2bM1b	Bd2	G3	6	11; DM + DD
18	87	M	Ascending colon	T4aN0M0	Bd2	G3	28	28
19	83	M	Sigmoid colon	T4N1bM0	Bd3	G3	38	38
20	84	F	Transverse colon	T4aN2aM0	Bd1	G1	0	0; DPC

DD, died of disease; DM, distant metastasis; DPC, died of perioperative complications, DUC, died of unrelated causes; LR, local disease recurrence; NED, no evidence of disease; TB, tumour budding; PDCs, poorly differentiated clusters.